查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2037367

藥品泡殼包裝市場：預測（至2034年）－按材料、產品類型、技術、劑型、應用類型、最終用戶和地區分類的全球分析

Pharmaceutical Blister Packaging Market Forecasts to 2034 - Global Analysis By Material, Product Type, Technology, Drug Form, Application Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球藥品泡殼包裝市場規模將達到 276 億美元，到 2034 年將達到 498 億美元，預測期內複合年成長率為 7.6%。

藥品泡殼包裝是一種預成型塑膠包裝解決方案，其內部空腔用於盛裝片劑和膠囊等固態劑型。它具有出色的產品保護阻隔性，能夠有效阻隔水分和氧氣，並具備防篡改功能。泡殼包裝可透過劑量追蹤提高病患用藥依從性，延長藥品保存期限，並支持單劑量分裝。因此，對於追求安全性、便利性和品牌差異化的製藥企業、合約包裝公司和藥房而言，泡殼包裝仍然是首選。

單劑量包裝的需求不斷成長，以及患者對藥物的依從性提高。

單劑量泡殼包裝的普及源於減少用藥錯誤和提高病患用藥依從性的需求，尤其是在醫院和長期照護機構。泡殼包裝能清楚標示日期和時間，幫助患者精準遵循複雜的用藥方案。對於製藥公司而言，單劑量包裝可以減少廢棄物並改善庫存管理。此外，監管機構也建議採用劑量適宜的包裝以提高安全性。隨著全球人口老化和慢性病的發病率上升，對泡殼包裝等便捷易用、預先配製好劑量的給藥系統的需求正在迅速成長，從而推動市場擴張。

模具成本高且材料有限

對於小批量生產和學名藥生產商而言，泡殼包裝模具（包括模頭和封口板）的初始投資可能非常昂貴。由於每種新產品和包裝設計都需要專用模具，因此前置作業時間更長，初始成本更高。此外，雖然PVC等傳統材料的阻隔性較低，但冷發泡箔等阻隔性替代材料會增加材料成本。多層複合材料也難以回收，帶來環境和監管的挑戰。這些經濟和材料方面的限制制約了泡殼包裝的普及，尤其對於對價格敏感的學名藥生產商和合約包裝公司而言更是如此。

環保可回收吸塑包裝材料的成長

日益嚴格的環境法規和不斷成長的消費者壓力正迫使包裝開發商開發永續的替代品，以取代傳統的PVC和PVDC吸塑包裝。創新方案包括完全可回收的單一材料聚丙烯（PP）和聚乙烯（PE）吸塑包裝，以及紙基和生質塑膠解決方案。大型製藥公司已設定包裝淨零排放目標，催生了對環保型吸塑包裝技術的強勁需求。此外，阻隔塗層技術的進步使得這些環保材料能夠提供與傳統複合材料相同的防護性能。這種轉變為材料供應商和包裝製造商提供了重要的機遇，使他們能夠脫穎而出，並獲得以永續發展為永續性的合約。

供應鏈不穩定與原物料價格波動

藥品泡殼包裝市場嚴重依賴PVC、PVDC和PE等石油化學衍生樹脂以及鋁箔。能源危機、地緣政治緊張局勢和貿易限制等全球動盪導致原料供應和價格快速波動。這些波動擠壓了包裝製造商的利潤空間，迫使合約包裝公司重新談判長期合約。此外，供應鏈延誤還會擾亂藥品生產計劃，導致供不應求。如果不採取採購多元化和材料替代策略，企業將持續面臨成本不穩定的風險，從而威脅市場成長和業務營運的穩定性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情初期，由於封鎖、勞動力短缺和非必需藥品產量下降，藥品泡殼包裝市場受到衝擊。然而，疫情迅速推高了對泡殼包裝的急救藥品、疫苗和非處方藥的需求。儘管鋁和塑膠供應鏈的瓶頸導致價格暫時上漲，但包裝製造商迅速做出反應，推進自動化生產，並與多家供應商簽訂原料合約。疫情也凸顯了單劑量包裝在感染控制中的重要性，因為泡殼包裝減少了人工操作。因此，市場展現出韌性，並進入復甦階段，同時更重視供應鏈的穩健性。

在預測期內，塑膠產業預計將佔據最大的市場佔有率。

塑膠製品預計將佔據最大的市場佔有率，這主要得益於其輕質、設計柔軟性和成本效益等優勢。聚氯乙烯（PVDC）則具有卓越的防潮性能。聚對苯二甲酸乙二醇酯（PETG）和聚乙烯（PE）因其透明度和永續性而備受關注。塑膠製品能夠實現快速熱成型，並允許對內容物進行透明檢查，因此對於品質控制和確保患者信任至關重要。

在預測期內，冷泡殼包裝細分市場預計將呈現最高的複合年成長率。

在預測期內，由於冷泡殼包裝具有卓越的阻隔水分、氧氣和光線的性能，預計將呈現最高的成長率。與熱成型泡殼不同，冷泡殼採用深模壓鋁箔層壓工藝，無需加熱，從而保持了生物製藥和激素等高度敏感分子的藥物穩定性。隨著個人化醫療的興起和對高活性原料藥需求的不斷成長，對藥物近乎完全的保護變得至關重要，這使得冷泡成型製程成為關鍵。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要得益於其成熟的製藥產業、處方藥的高消費量，以及美國食品藥品監督管理局（FDA）對包裝的嚴格要求，這些要求旨在確保兒童和老年人用藥安全。美國和加拿大擁有眾多大型製藥企業和合約包裝公司，為持續創新提供了支持。此外，對病人用藥依從性和用藥依從性項目的重視也推動了單劑量泡殼包裝的使用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國和印度藥品生產的擴張、學名藥消費量的成長以及東南亞醫療保健服務可及性的改善。快速發展的契約製造和包裝行業正在部署最先進的泡殼包裝生產線，以服務國內和出口市場。可支配收入的成長和慢性病發病率的上升推動了對包裝好的成藥和處方藥的需求增加，從而加速了泡殼包裝的普及。

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他公司（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 成長要素、挑戰與機遇
  • 競爭格局概述
  • 戰略考慮和建議

第2章：分析框架

  • 分析的目標和範圍
  • 相關人員分析
  • 分析的前提條件與限制
  • 分析方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 科技與創新趨勢
  • 新興市場和高成長市場
  • 監管和政策環境
  • 感染疾病的影響及恢復前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商議價能力
    • 買方的議價能力
    • 替代產品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球藥品泡殼包裝市場：依材料分類

  • 塑膠
    • 聚氯乙烯
    • Polyvinylidene氯乙烯
    • PETG
    • 聚乙烯（PE）
  • 鋁箔
  • 紙張和紙板
  • 多層複合
  • 其他材料

第6章 全球藥品泡殼包裝市場：依產品類型分類

  • 吸塑包裝
  • 卡片式吸塑包裝
  • 熱成型吸塑包裝
  • 冷泡殼包裝
  • 面封吸塑包裝
  • 完全密封的吸塑包裝
  • 其他產品類型

第7章 全球藥品泡殼包裝市場：依技術分類

  • 熱成型
  • 冷成型
  • 熱封

第8章 全球藥品泡殼包裝市場：以劑型分類

  • 藥片
  • 膠囊
  • 口服薄膜製劑及錠劑
  • 注射劑/安瓿
  • 診斷試劑盒和醫療設備

第9章 全球藥品泡殼包裝市場：依應用類型分類

  • 處方藥
  • 非處方藥
  • 營養保健品

第10章 全球藥品泡殼包裝市場：依最終用戶分類

  • 製藥公司
  • 合約包裝營運商 (CPO)
  • 醫院和診所
  • 零售藥房
  • 網路藥房
  • 其他最終用戶

第11章 全球藥品泡殼包裝市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 產業加值網路與供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 企業合併（M&A）
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Amcor plc
  • Constantia Flexibles
  • Tekni-Plex, Inc.
  • Sonoco Products Company
  • WestRock Company
  • Huhtamaki Oyj
  • Klockner Pentaplast Group
  • ACG Pharmapack Pvt. Ltd.
  • AptarGroup, Inc.
  • Perlen Packaging
  • Honeywell International Inc.
  • Bilcare Research Inc.
  • Winpak Ltd.
  • UFlex Ltd.
  • Ecobliss Pharmaceutical Packaging
Product Code: SMRC35779

According to Stratistics MRC, the Global Pharmaceutical Blister Packaging Market is accounted for $27.6 billion in 2026 and is expected to reach $49.8 billion by 2034, growing at a CAGR of 7.6% during the forecast period. Pharmaceutical blister packaging is a pre-formed plastic packaging solution that provides cavity spaces for solid dosage forms such as tablets and capsules. It offers excellent product protection, barrier properties against moisture and oxygen, and tamper evidence. Blister packaging enhances patient compliance through dose tracking, extends shelf life, and supports unit-dose dispensing. As a result, it remains a preferred choice for drug manufacturers, contract packagers, and pharmacies aiming for safety, convenience, and brand differentiation.

Market Dynamics:

Driver:

Rising demand for unit-dose packaging and patient compliance

The shift toward unit-dose blister packaging is being driven by the need to reduce medication errors and improve patient adherence, particularly in hospital and long-term care settings. Blister packs allow for clear labeling of day and time, enabling patients to follow complex dosage regimens accurately. For pharmaceutical manufacturers, unit-dose formats reduce waste and enable better inventory management. Additionally, regulatory bodies are encouraging dose-specific packaging to enhance safety. As the global population ages and chronic diseases become more prevalent, the demand for easy-to-use, pre-measured drug delivery systems like blister packs is growing rapidly, fueling market expansion.

Restraint:

High tooling costs and material limitations

The initial investment in blister packaging tooling, including forming dies and sealing plates, can be prohibitively expensive for small-batch or generic drug producers. Each new product or pack design requires custom tooling, leading to longer lead times and higher upfront costs. Furthermore, traditional materials like PVC have poor barrier properties, while high-barrier alternatives such as cold-form foil increase material expenses. The lack of recyclability for multi-layer laminates also poses environmental and regulatory challenges. These economic and material constraints limit the adoption of blister packaging, especially among price-sensitive generic drug manufacturers and contract packaging organizations.

Opportunity:

Growth of eco-friendly and recyclable blister materials

Increasing environmental regulations and consumer pressure are pushing packaging developers to create sustainable alternatives to traditional PVC and PVDC blisters. Innovations include mono-material polypropylene (PP) and polyethylene (PE) blisters that are fully recyclable, as well as paper-based and bio-plastic solutions. Major pharmaceutical companies are setting net-zero packaging goals, creating a strong demand for green blister technologies. Additionally, advancements in barrier coatings allow these eco-friendly materials to match the protective performance of conventional laminates. This shift presents a significant opportunity for material suppliers and packagers to differentiate themselves and capture sustainability-focused contracts.

Threat:

Supply chain volatility and raw material price fluctuations

The pharmaceutical blister packaging market is highly dependent on petrochemical-derived resins such as PVC, PVDC, and PE, as well as aluminum foil. Global disruptions-including energy crises, geopolitical tensions, and trade restrictions-have led to sharp fluctuations in raw material availability and pricing. This volatility squeezes profit margins for packaging converters and forces contract packaging organizations to renegotiate long-term agreements. Additionally, supply chain delays can interrupt drug production schedules, leading to shortages. Without diversified sourcing or material substitution strategies, companies remain vulnerable to cost instability, which threatens market growth and operational predictability.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the pharmaceutical blister packaging market due to lockdowns, labor shortages, and reduced production of non-essential drugs. However, the crisis rapidly accelerated demand for blister-packed emergency medications, vaccines, and over-the-counter remedies. Supply chain bottlenecks for aluminum and plastics caused temporary price spikes, but packaging manufacturers quickly adapted by increasing automation and securing multi-source raw material contracts. The pandemic also highlighted the importance of unit-dose packaging for infection control, as blisters reduce manual handling. Consequently, the market demonstrated resilience and entered a recovery phase with strengthened focus on supply chain robustness.

The plastic segment is expected to be the largest during the forecast period

The plastic segment is expected to account for the largest market share, driven by its lightweight nature, design flexibility, and cost-effectiveness. Polyvinyl chloride (PVC) remains widely used for standard drugs due to its excellent thermoforming properties, while polyvinylidene chloride (PVDC) offers enhanced moisture protection. PETG and PE are gaining traction for their clarity and sustainability profiles. Plastics enable high-speed thermoforming and transparent visibility of contents, which is critical for quality checks and patient reassurance.

The cold form blister packs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, cold form blister packs are predicted to witness the highest growth rate, due to their superior barrier properties against moisture, oxygen, and light. Unlike thermoformed blisters, cold form packs use aluminum foil laminates that are deeply drawn without heat, preserving drug stability for highly sensitive molecules such as biologics and hormones. The rise of personalized medicine and potent APIs requires near-absolute protection, making cold forming indispensable.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a well-established pharmaceutical industry, high prescription drug consumption, and stringent FDA requirements for child-resistant and senior-friendly packaging. The presence of major drug manufacturers and contract packaging organizations in the US and Canada supports continuous innovation. Additionally, a strong focus on patient compliance and medication adherence programs encourages the use of unit-dose blister packs.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by expanding pharmaceutical production in China and India, rising generic drug consumption, and increasing healthcare access in Southeast Asia. Rapidly growing contract manufacturing and packaging sectors are adopting modern blister lines to serve both domestic and export markets. As disposable incomes rise and chronic diseases increase, demand for packaged OTC and prescription drugs accelerates blister adoption.

Key players in the market

Some of the key players in Pharmaceutical Blister Packaging Market include Amcor plc, Constantia Flexibles, Tekni-Plex, Inc., Sonoco Products Company, WestRock Company, Huhtamaki Oyj, Klockner Pentaplast Group, ACG Pharmapack Pvt. Ltd., AptarGroup, Inc., Perlen Packaging, Honeywell International Inc., Bilcare Research Inc., Winpak Ltd., UFlex Ltd., and Ecobliss Pharmaceutical Packaging.

Key Developments:

In March 2026, Amcor announced the launch of its new recyclable PE-based blister film designed for over-the-counter drugs, offering high moisture barrier without PVC or PVDC. The product is compatible with existing thermoforming lines and has received validation from multiple European contract packagers.

In January 2026, Tekni-Plex expanded its manufacturing facility in Suzhou, China, to increase production of cold-form blister foils by 40%. This expansion aims to meet growing regional demand for high-barrier packaging of sensitive biologics and generic injectable drugs, serving both domestic and export markets.

Materials Covered:

  • Plastic
  • Aluminum Foil
  • Paper & Paperboard
  • Multi-layer Laminates
  • Other Materials

Product Types Covered:

  • Clamshell Blister Packaging
  • Carded Blister Packaging
  • Thermoform Blister Packs
  • Cold Form Blister Packs
  • Face Seal Blister Packs
  • Full-face Seal Blister Packs
  • Other Product Types

Technologies Covered:

  • Thermoforming
  • Cold Forming
  • Heat Sealing

Drug Forms Covered:

  • Tablets
  • Capsules
  • Oral Thin Films & Lozenges
  • Injectables & Ampoules
  • Diagnostic Kits & Medical Devices

Application Types Covered:

  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs
  • Nutraceuticals & Supplements

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Packaging Organizations (CPOs)
  • Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pharmaceutical Blister Packaging Market, By Material

  • 5.1 Plastic
    • 5.1.1 Polyvinyl Chloride
    • 5.1.2 Polyvinylidene Chloride
    • 5.1.3 PETG
    • 5.1.4 PE
  • 5.2 Aluminum Foil
  • 5.3 Paper & Paperboard
  • 5.4 Multi-layer Laminates
  • 5.5 Other Materials

6 Global Pharmaceutical Blister Packaging Market, By Product Type

  • 6.1 Clamshell Blister Packaging
  • 6.2 Carded Blister Packaging
  • 6.3 Thermoform Blister Packs
  • 6.4 Cold Form Blister Packs
  • 6.5 Face Seal Blister Packs
  • 6.6 Full-face Seal Blister Packs
  • 6.7 Other Product Types

7 Global Pharmaceutical Blister Packaging Market, By Technology

  • 7.1 Thermoforming
  • 7.2 Cold Forming
  • 7.3 Heat Sealing

8 Global Pharmaceutical Blister Packaging Market, By Drug Form

  • 8.1 Tablets
  • 8.2 Capsules
  • 8.3 Oral Thin Films & Lozenges
  • 8.4 Injectables & Ampoules
  • 8.5 Diagnostic Kits & Medical Devices

9 Global Pharmaceutical Blister Packaging Market, By Application Type

  • 9.1 Prescription Drugs
  • 9.2 Over-the-Counter (OTC) Drugs
  • 9.3 Nutraceuticals & Supplements

10 Global Pharmaceutical Blister Packaging Market, By End User

  • 10.1 Pharmaceutical Manufacturers
  • 10.2 Contract Packaging Organizations (CPOs)
  • 10.3 Hospitals & Clinics
  • 10.4 Retail Pharmacies
  • 10.5 Online Pharmacies
  • 10.6 Other End Users

11 Global Pharmaceutical Blister Packaging Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Amcor plc
  • 14.2 Constantia Flexibles
  • 14.3 Tekni-Plex, Inc.
  • 14.4 Sonoco Products Company
  • 14.5 WestRock Company
  • 14.6 Huhtamaki Oyj
  • 14.7 Klockner Pentaplast Group
  • 14.8 ACG Pharmapack Pvt. Ltd.
  • 14.9 AptarGroup, Inc.
  • 14.10 Perlen Packaging
  • 14.11 Honeywell International Inc.
  • 14.12 Bilcare Research Inc.
  • 14.13 Winpak Ltd.
  • 14.14 UFlex Ltd.
  • 14.15 Ecobliss Pharmaceutical Packaging

List of Tables

  • Table 1 Global Pharmaceutical Blister Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pharmaceutical Blister Packaging Market Outlook, By Material (2023-2034) ($MN)
  • Table 3 Global Pharmaceutical Blister Packaging Market Outlook, By Plastic (2023-2034) ($MN)
  • Table 4 Global Pharmaceutical Blister Packaging Market Outlook, By Polyvinyl Chloride (2023-2034) ($MN)
  • Table 5 Global Pharmaceutical Blister Packaging Market Outlook, By Polyvinylidene Chloride (2023-2034) ($MN)
  • Table 6 Global Pharmaceutical Blister Packaging Market Outlook, By PETG (2023-2034) ($MN)
  • Table 7 Global Pharmaceutical Blister Packaging Market Outlook, By PE (2023-2034) ($MN)
  • Table 8 Global Pharmaceutical Blister Packaging Market Outlook, By Aluminum Foil (2023-2034) ($MN)
  • Table 9 Global Pharmaceutical Blister Packaging Market Outlook, By Paper & Paperboard (2023-2034) ($MN)
  • Table 10 Global Pharmaceutical Blister Packaging Market Outlook, By Multi-layer Laminates (2023-2034) ($MN)
  • Table 11 Global Pharmaceutical Blister Packaging Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 12 Global Pharmaceutical Blister Packaging Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 13 Global Pharmaceutical Blister Packaging Market Outlook, By Clamshell Blister Packaging (2023-2034) ($MN)
  • Table 14 Global Pharmaceutical Blister Packaging Market Outlook, By Carded Blister Packaging (2023-2034) ($MN)
  • Table 15 Global Pharmaceutical Blister Packaging Market Outlook, By Thermoform Blister Packs (2023-2034) ($MN)
  • Table 16 Global Pharmaceutical Blister Packaging Market Outlook, By Cold Form Blister Packs (2023-2034) ($MN)
  • Table 17 Global Pharmaceutical Blister Packaging Market Outlook, By Face Seal Blister Packs (2023-2034) ($MN)
  • Table 18 Global Pharmaceutical Blister Packaging Market Outlook, By Full-face Seal Blister Packs (2023-2034) ($MN)
  • Table 19 Global Pharmaceutical Blister Packaging Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 20 Global Pharmaceutical Blister Packaging Market Outlook, By Technology (2023-2034) ($MN)
  • Table 21 Global Pharmaceutical Blister Packaging Market Outlook, By Thermoforming (2023-2034) ($MN)
  • Table 22 Global Pharmaceutical Blister Packaging Market Outlook, By Cold Forming (2023-2034) ($MN)
  • Table 23 Global Pharmaceutical Blister Packaging Market Outlook, By Heat Sealing (2023-2034) ($MN)
  • Table 24 Global Pharmaceutical Blister Packaging Market Outlook, By Drug Form (2023-2034) ($MN)
  • Table 25 Global Pharmaceutical Blister Packaging Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 26 Global Pharmaceutical Blister Packaging Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 27 Global Pharmaceutical Blister Packaging Market Outlook, By Oral Thin Films & Lozenges (2023-2034) ($MN)
  • Table 28 Global Pharmaceutical Blister Packaging Market Outlook, By Injectables & Ampoules (2023-2034) ($MN)
  • Table 29 Global Pharmaceutical Blister Packaging Market Outlook, By Diagnostic Kits & Medical Devices (2023-2034) ($MN)
  • Table 30 Global Pharmaceutical Blister Packaging Market Outlook, By Application Type (2023-2034) ($MN)
  • Table 31 Global Pharmaceutical Blister Packaging Market Outlook, By Prescription Drugs (2023-2034) ($MN)
  • Table 32 Global Pharmaceutical Blister Packaging Market Outlook, By Over-the-Counter (OTC) Drugs (2023-2034) ($MN)
  • Table 33 Global Pharmaceutical Blister Packaging Market Outlook, By Nutraceuticals & Supplements (2023-2034) ($MN)
  • Table 34 Global Pharmaceutical Blister Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 35 Global Pharmaceutical Blister Packaging Market Outlook, By Pharmaceutical Manufacturers (2023-2034) ($MN)
  • Table 36 Global Pharmaceutical Blister Packaging Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)
  • Table 37 Global Pharmaceutical Blister Packaging Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 38 Global Pharmaceutical Blister Packaging Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 39 Global Pharmaceutical Blister Packaging Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 40 Global Pharmaceutical Blister Packaging Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.